Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Celltex, Citius, Cytocom, Daiichi Sankyo, Eisai, EMD Serono, Fulcrum, Gilead Sciences, Immunovative, Incyte, Mayne, Merz, Mirror Biologics, Neurorx, Novartis, Novo Nordisk, Rakuten Medical, Relief, Renibus, Roche, Samsung Bioepis, Sinovac, Teijin.